- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06577662
Effects of an Individual and Family Self-Management of Fall Prevention Program on Balance Ability and Fall-related Self-efficacy Among Chinese Post-Stroke Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guizhou
-
Guiyang, Guizhou, China, 550004
- Affiliated Hospital of Guizhou Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
For patients
- aged 18 years or above;
- first-ever diagnosed with ischemic stroke;
- level of impairment assessed by the National Institutes of Health Stroke Scale (NIHSS) scores between 5 to 15 (moderate severity) before entering the experiment;
- mental state assessed by Mini-Mental State Exam score > 24;
- mobility tested by Timed Up and Go ≥12.6 second (walkers or another kinds of gait aid are allowed to be used in the test);
- motor power of all limbs examined by muscle power assessment grade ≥3;
- ability to understand Chinese;
- living with family members;
- having phones that can use the internet;
- willing to join the study.
For caregivers
- mental state assessed by Short Portable Mental Status Questionnaire score ≥8;
- being the primary caregiver, living in the same house, and taking care of the patient;
- having phones that can use the internet;
- can speak, understand, and write in Chinese; and (e) willing to participate.
Exclusion Criteria for patients:
- having problems with sensory and/or global aphasia
Discontinuation criteria:
- patients have an illness that needs hospitalization;
- patients and caregivers cannot complete participation in intervention sessions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: individual and family self-management (IFSM) fall prevention program
The IFSM program will be last for ten weeks, two weeks in the hospital, and follow up at eight weeks after patients discharge to home.
It includes 11 sessions, including ten sessions developed in the inpatient department within two weeks and one online booster session developed in the first month (week 4) after discharge in home.
There will be also one session just for caregivers, which aims to improve caregivers' skills to keep patients' safety.
In the process, self-efficacy strategies, self-regulation skills, and social facilitation are used in every session.
The main self-efficacy strategies includes skill mastery, vicarious experience, and verbal persuasion.
Several self-regulation skills for patients and caregivers are also used in the study, such as self-monitoring and reflective thinking.
A WeChat group will be established to support patients and their families.
|
The IFSM program will last for ten weeks, two weeks in the hospital, and follow up at eight weeks after patients discharge to home. It will include 11 sessions, including ten sessions developed in the inpatient department within two weeks and one online booster session developed in the first month (week 4) after discharge in home. There will be also one session just for caregivers. Session 1 : PRST combined with GRI (one) Session 2 : Environment safety Session 3 : Assistant technology Session 4 : PRST combined with GRI (two) Session 5 : Medication review Session 6 : Safety in daily activities Session 7 : How to keep loved one safety Session 8 : Review of PRST combined with GRI Session 9 : Review of other five fall prevention skills Session 10 : Summary of the program and setting goals Session 11 : Booster session Week 10: Evaluation |
|
No Intervention: usual care
Participants in the control group will receive usual care, including standard clinical practices such as education on fall prevention and a fall prevention booklet.
The education will be delivered by the researcher and does not include any additional intervention specific to the study.
A fall prevention care plan will be manually documented in the electronic health record.
After the patients are discharged home, a phone visit will be provided for patients within the first month, which will include a medication review and professional access.
Participants will also use a fall record diary to record falls in the control group, and this will be copied for data extraction after the experiment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fall-related self-efficacy
Time Frame: Fall-related self-efficacy will be measured before the fall prevention program and after patients are discharged in 8 weeks.
|
Fall-related self-efficacy refers to the level of perceived confidence in undertaking everyday activities without falling, which includes self-efficacy in balance ability, preventing falls, and managing falls.
The Short Falls Efficacy Scale-International (Short FES-I) will be used to assess fall-related self-efficacy; it consists of seven questions.
A four-point scale is used to score each item, and a higher score indicates lower self-efficacy.
The total score is calculated by adding the scores of each item, giving a scale ranging from 7 to 28 for the seven items.
The Short FES-I has previously demonstrated excellent reliability (Cronbach's α = 0.92).
|
Fall-related self-efficacy will be measured before the fall prevention program and after patients are discharged in 8 weeks.
|
|
Balance ability
Time Frame: Balance ability will be measured before the fall prevention program and after patients are discharged in 8 weeks.
|
Balance ability is the ability to maintain the body's stability, including keeping a certain posture or balance when subjected to external forces.
Berg Balance Scale (BBS) will be used to assess the balance ability in post-stroke people.
The BBS will be used to assess balance ability in post-stroke individuals.
It consists of 14 items, each rated on a five-point scale.
A score of 41-56 indicates the ability to walk independently, 21-40 indicates the ability to walk with assistance, and 0-20 indicates wheelchair-bound movement.
In different studies on patients with stroke, the BBS has been found to have excellent internal consistency, with Cronbach alphas ranging from 0.92 to 0.98
|
Balance ability will be measured before the fall prevention program and after patients are discharged in 8 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of falls, fall-related injuries and Adverse Events
Time Frame: Number of falls and fall-related injuries will be measured after patients are discharged in 8 weeks
|
Number of falls and fall-related injuries will be measured after patients are discharged in 8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2567-FULL018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Access to the de-identified individual participant data (IPD) and supporting documentation (such as the study protocol, statistical analysis plan, and informed consent form) will be granted to qualified researchers affiliated with academic or non-profit institutions.
Researchers must submit a methodologically sound research proposal along with a data access request to the corresponding author. The request will be reviewed by the study team to ensure alignment with the original study objectives and participant privacy protections.
Upon approval, a data use agreement will be signed. Data will be shared via secure email or a secure file-sharing platform, depending on the nature and size of the data.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.